Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Curis (CRIS) Cash & Equivalents (2016 - 2026)

Curis filings provide 16 years of Cash & Equivalents readings, the most recent being $5.1 million for Q4 2025.

  • On a quarterly basis, Cash & Equivalents fell 74.69% to $5.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.1 million, a 74.69% decrease, with the full-year FY2025 number at $5.1 million, down 74.69% from a year prior.
  • Cash & Equivalents hit $5.1 million in Q4 2025 for Curis, down from $9.1 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $111.0 million in Q1 2021 to a low of $5.1 million in Q4 2025.
  • Median Cash & Equivalents over the past 5 years was $22.7 million (2023), compared with a mean of $30.5 million.
  • Biggest five-year swings in Cash & Equivalents: soared 785.98% in 2021 and later tumbled 83.37% in 2022.
  • Curis' Cash & Equivalents stood at $40.0 million in 2021, then tumbled by 50.87% to $19.7 million in 2022, then soared by 35.73% to $26.7 million in 2023, then fell by 25.05% to $20.0 million in 2024, then plummeted by 74.69% to $5.1 million in 2025.
  • The last three reported values for Cash & Equivalents were $5.1 million (Q4 2025), $9.1 million (Q3 2025), and $10.1 million (Q2 2025) per Business Quant data.